About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Beyond 1L EGFRm mNSCLC Management: Today’s Challenges, Tomorrow’s Approach
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
ADCs and Bispecific Inhibitors in NSCLC
By
Chul Kim
8 Videos
460 views
March 29, 2024
0 Comments
Login to view comments.
Click here to Login
11:22
UCLA Health
HERTHENA-Lung01 Study: Patritumab Deruxtecan as a HER3 Target in EGF…
Feat.
A. Lisberg
13:17
Joshua Reuss
ADCs in Lung Cancer: A Transformative Therapeutic Class?
16:17
Timothy Burns
Non-TKI-Based Strategies for EGFR Common Mutations
20:28
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
Feat.
C. Aggarwal
20:43
GRACE
Newer Types of Treatment for Lung Cancer: ADCs and Bispecifics
Feat.
L. Bazhenova
23:50
GRACE
Targeted Therapies in Lung Cancer 2023: EGFR Targeted Therapies in N…
Feat.
I. Preeshagul
06:44
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "The Impact of PET-CT Brain MRI for Metasta…
Feat.
W. Liang
09:47
GRACE
Overcoming Resistance in EGFR+ NSCLC
Feat.
A. Desai
